NCT02211352View on ClinicalTrials.gov

Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

July 31, 2014

Conditions
Hypertension
Interventions
DRUG

Korean Red Ginseng Capsules

Korean Red Ginseng Capsules 2mg,daily, 8 week and than crossover to placebo capsules(2g), daily 8week

DRUG

Placebo

Korean Red Ginseng Capsules 2mg,daily, 8 week and than crossover to placebo capsules(2g), daily 8week

Trial Locations (1)

705-718

Daegu Catholic University Medical Center, Daegu

All Listed Sponsors
collaborator

The Korean Society of Ginseng

OTHER

lead

Daegu Catholic University Medical Center

OTHER

NCT02211352 - Effect of Korean Red Ginseng on Central Blood Pressure in Patient With Essential Hypertension | Biotech Hunter | Biotech Hunter